GH1 and growth delay due to insulin-like growth factor type 1 deficiency: Assessment of prevalence and clinical relevance of GH and IGF-1 deficiency in a large population of CHF patients not only may help understanding of GH/IGF-1 physiology in CHF, but could also pave the way for innovative therapeutic approaches, such as GH replacement therapy [6, 7].